Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-004645

Options or other derivatives

  • SVP, Chief Financial Officer acquired 40,796 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sun Elaine D · SVP, Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2020-04-01 Grant or award : show line 1 in the form Performance Stock Units +40,796 $0.00 40,796 40,796 D
Loading xslF345X03/edgar.xml…